137 related articles for article (PubMed ID: 37573454)
1. Modified influenza M1
Lanfermeijer J; van de Ven K; van Dijken H; Hendriks M; Talavera Ormeño CMP; de Heij F; Roholl P; Borghans JAM; van Baarle D; de Jonge J
NPJ Vaccines; 2023 Aug; 8(1):116. PubMed ID: 37573454
[TBL] [Abstract][Full Text] [Related]
2. Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
Rosendahl Huber SK; Luimstra JJ; van Beek J; Hoppes R; Jacobi RH; Hendriks M; Kapteijn K; Ouwerkerk C; Rodenko B; Ovaa H; de Jonge J
PLoS One; 2016; 11(6):e0156462. PubMed ID: 27333291
[TBL] [Abstract][Full Text] [Related]
3. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
[TBL] [Abstract][Full Text] [Related]
4. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice.
Tan AC; La Gruta NL; Zeng W; Jackson DC
J Immunol; 2011 Aug; 187(4):1895-902. PubMed ID: 21765016
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.
Valkenburg SA; Josephs TM; Clemens EB; Grant EJ; Nguyen TH; Wang GC; Price DA; Miller A; Tong SY; Thomas PG; Doherty PC; Rossjohn J; Gras S; Kedzierska K
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4440-5. PubMed ID: 27036003
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Approach to Influenza-Specific CD8
Sant S; Grzelak L; Wang Z; Pizzolla A; Koutsakos M; Crowe J; Loudovaris T; Mannering SI; Westall GP; Wakim LM; Rossjohn J; Gras S; Richards M; Xu J; Thomas PG; Loh L; Nguyen THO; Kedzierska K
Front Immunol; 2018; 9():1453. PubMed ID: 29997621
[TBL] [Abstract][Full Text] [Related]
7. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
8. Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age.
Gil A; Yassai MB; Naumov YN; Selin LK
J Virol; 2015 Apr; 89(8):4102-16. PubMed ID: 25609818
[TBL] [Abstract][Full Text] [Related]
9. Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
Hoppes R; Oostvogels R; Luimstra JJ; Wals K; Toebes M; Bies L; Ekkebus R; Rijal P; Celie PH; Huang JH; Emmelot ME; Spaapen RM; Lokhorst H; Schumacher TN; Mutis T; Rodenko B; Ovaa H
J Immunol; 2014 Nov; 193(10):4803-13. PubMed ID: 25311806
[TBL] [Abstract][Full Text] [Related]
10. HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells.
Sant S; Quiñones-Parra SM; Koutsakos M; Grant EJ; Loudovaris T; Mannering SI; Crowe J; van de Sandt CE; Rimmelzwaan GF; Rossjohn J; Gras S; Loh L; Nguyen THO; Kedzierska K
PLoS Pathog; 2020 Aug; 16(8):e1008714. PubMed ID: 32750095
[TBL] [Abstract][Full Text] [Related]
11. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
[TBL] [Abstract][Full Text] [Related]
12. Understanding CD8
Nguyen TH; Tan AC; Xiang SD; Goubier A; Harland KL; Clemens EB; Plebanski M; Kedzierska K
Clin Transl Immunology; 2017 Mar; 6(3):e134. PubMed ID: 28435676
[TBL] [Abstract][Full Text] [Related]
13. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
14. Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.
Soema PC; Rosendahl Huber SK; Willems GJ; Jiskoot W; Kersten GF; Amorij JP
Pharm Res; 2015 Apr; 32(4):1505-15. PubMed ID: 25344321
[TBL] [Abstract][Full Text] [Related]
15. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
[TBL] [Abstract][Full Text] [Related]
16. Homologous peptides derived from influenza A, B and C viruses induce variable CD8
Nguyen AT; Lau HMP; Sloane H; Jayasinghe D; Mifsud NA; Chatzileontiadou DS; Grant EJ; Szeto C; Gras S
Clin Transl Immunology; 2022; 11(10):e1422. PubMed ID: 36275878
[TBL] [Abstract][Full Text] [Related]
17. Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8
Soema PC; Rosendahl Huber SK; Willems GJ; Jacobi R; Hendriks M; Soethout E; Jiskoot W; de Jonge J; van Beek J; Kersten GFA; Amorij JP
Front Immunol; 2018; 9():525. PubMed ID: 29593747
[TBL] [Abstract][Full Text] [Related]
18. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.
Hemann EA; Kang SM; Legge KL
J Immunol; 2013 Sep; 191(5):2486-94. PubMed ID: 23885108
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease.
Herrmann VL; Hartmayer C; Planz O; Groettrup M
J Control Release; 2015 Oct; 216():121-31. PubMed ID: 26276509
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.
Shah S; Cook KW; Symonds P; Weißer J; Skinner A; Al Omari A; Paston SJ; Pike I; Durrant LG; Brentville VA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
